Ann: Investor presentation - quarterly update, page-6

I think Pharmaxis changing their name is a step in the right direction as I think Pharmaxis leaves a bad taste with many investors.

I really want to believe in Pxs/ syn however my belief in them is slowly being chipped away.

They sold Orbital for 5 million US, from what I’ve heard and read it sounds like they’ve given away Aridol and Bronchitol,

They want to focus on being a clinical stage drug development company. They have some great products in the pipeline if they come to fruition, my concern is will they know how to make a profit from the products given their history? Grrrrr